Erlinda Maria Gordon
Presidente presso GenVivo, Inc.
Profilo
Erlinda Maria Gordon co-founded Epeius Biotechnologies Corp.
in 2000 and currently serves as Chairman and Vice President of Operations and Medical Affairs.
Previously, she was Associate Professor of Pediatrics, Medical Director of the Vector Production Unit, and Director of the Molecular Therapeutics Division of the Gene Therapy for the Keck School of Medicine at the University of Southern California.
Dr. Gordon has experience in pediatric cancer and hemophilia.
She received an MD degree from the University of Santo Tomas School of Medicine and Surgery in 1971.
Posizioni attive di Erlinda Maria Gordon
| Società | Posizione | Inizio |
|---|---|---|
GenVivo, Inc.
 GenVivo, Inc. BiotechnologyHealth Technology GenVivo, Inc. develops targeted delivery system that transports genes directly to diseased areas in the body. Its products are used for the treatment of metastatic cancer. The company was founded in 2000 by Erlinda Maria Gordon and Frederick L. Hall and is headquartered in San Marino, CA. | Presidente | 01/01/2000 |
Precedenti posizioni note di Erlinda Maria Gordon
| Società | Posizione | Fine |
|---|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
Formazione di Erlinda Maria Gordon
| University of Santo Tomas | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
GenVivo, Inc.
GenVivo, Inc. BiotechnologyHealth Technology GenVivo, Inc. develops targeted delivery system that transports genes directly to diseased areas in the body. Its products are used for the treatment of metastatic cancer. The company was founded in 2000 by Erlinda Maria Gordon and Frederick L. Hall and is headquartered in San Marino, CA. | Health Technology |
- Borsa valori
- Insiders
- Erlinda Maria Gordon